Radiation-Free Whole Body MRI for Children With Cancer

Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

Recruiting Phase 1 Phase 2 Interventional Study
Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
6 – 40
Sex
Any
Trial phase
Phase 1/2
Study type
Interventional
Purpose
Diagnostic
Participants needed
75 (estimated)
Sponsor
Heike E Daldrup-Link · Other
Who this trial is looking for

This trial is looking for children with certain types of cancer to test a new imaging technique. Participants will undergo whole body MR and PET/MR scans to see how well they can detect the spread of disease without radiation exposure.

Are You a Good Fit for This Trial?
Rules you out HemosiderosisHemochromatosis

You may be able to join if

  • I have been diagnosed with a solid extra-cranial tumor.
  • I am scheduled for or have completed a PET or PET/CT tumor staging procedure.
  • I have not had any restrictions on prior treatment.

You may not be able to join if

  • I have metal implants that are not compatible with MRI.
  • I need sedation or feel claustrophobic.
  • I have a history of allergic reactions to iron compounds or similar drugs.
  • I am pregnant.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
A research study on the diagnosis of spread of disease for children who have been diagnosed with solid tumors using a new whole body imaging technique and a new MR contrast agent (ferumoxytol). Standard tests that are used to determine the extent and possible spread of a child's disease include magnetic resonance (MR) imaging, computed tomography (CT), Positron Emission Tomography (PET) as well as…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Diagnosis of a solid extra-cranial tumor like malignant lymphoma or malignant sarcoma and * Scheduled for or completed a 18F-FDG-PET or 18F-FDG-PET/CT tumor staging procedure. * There will be no restrictions on prior treatment. * Very young children who need sedation or anesth…
Contacts

Lucia Barrato

415 307 1990

lbaratto@stanford.edu

CONTACT